| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |